Related Experiment Video
Updated: Jan 7, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
Inhibition of c-Jun/Bak signaling alleviates endothelial cell senescence and inflammation caused by mitochondrial
Ma Jianxiong1, Guo Yingxue2, Zhongliao Zeng2
1Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, 310000, China; Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Hangzhou, Zhejiang, 310000, China.
Abstract:
Endothelial dysfunction is a key contributor to diabetic complications, including erectile dysfunction (ED). Using single-cell RNA sequencing and transcriptomic analysis of diabetic ED (DMED), this study identifies the c-Jun/Bak pathway as a key driver of endothelial aging and inflammation. Hyperglucose-induced c-Jun/Bak activation initiates Bak-dependent mitochondrial dysfunction manifested as structural damage, excessive ROS production, and metabolic dysfunction. In DMED rats, penile corpus cavernosal endothelial cells exhibit elevated markers of senescence as well as overactivation of JNK and mitochondrial abnormalities. In vitro experiments showed that JNK inhibition protected mitochondrial function and attenuated aging and inflammation, whereas Bak activation reversed these benefits. While rodent models provide mechanistic insights, translational challenges require further investigation due to the complexity of human diabetes. These findings highlight mitochondrial regulation of c-Jun/Bak signaling as a therapeutic target for diabetic vascular complications, providing a novel approach for the treatment of DMED.
Related Concept Videos
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
The Intrinsic Apoptotic Pathway

